| abstract |
The invention relates to a combination of interferon-alpha and C-phycocyanin (IFN-alpha/ C-Phyco), which is used to obtain a pharmaceutical preparation for the treatment of autoimmune diseases, allergic diseases and cancer. The anti-inflammatory, immunomodulatory, antioxidant, antiviral, antiproliferative and antitumour effects which are associated with the inducing effect of regulatory T cells, which is shown in the invention, justify the use of the IFN-alpha/C-Phyco combination for said diseases. |